​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ · Alberta Health Services

June 24, 2024 - The FDA has approved a vaccine for pregnant women and infants to provide immediate protection against respiratory syncytial virus, or RSV.

Discuss with your pharmacist to determine which vaccine is most appropriate for you based on your age, health status, and other individual factors. It is the most common cause of bronchiolitis, meaning inflammation of the small airways in the lung. It is also a common cause of pneumonia, an infection of the lungs, among infants and young children. RSV ...

Data showed overall vaccine efficacy against RSV-lower respiratory tract disease in adults aged 60 years and above

December 12, 2023 - Respiratory syncytial (pronounced ‘sin-SISH-uhl’) virus, or RSV, is a major cause of respiratory illness in all age groups. RSV usually causes mild, cold-like symptoms and most people usually recover in week or two.

RSV (Respiratory Syncytial Virus) Vaccine, mRNA: learn about side effects, dosage, special precautions, and more on MedlinePlus

December 6, 2022 - Respiratory syncytial virus (RSV) is spreading quickly with physical distancing no longer a reality. Learn about prospects for an RSV vaccine.

This activity provides comprehensive ... teams to identify patients at high risk of severe RSV infection outcomes and to recommend and administer the RSVPreF3 vaccine according to nationally accepted guidelines....

COVID, Flu and RSV vaccines, tests, and treatments - information about FDA-approved and authorized medical products for seasonal respiratory illnesses

Respiratory syncytial virus (RSV) disease is an important cause of morbidity and mortality in children and debilitated adults and remains one of the major global unmet challenges for vaccine development. Several immunological issues have delayed the ...

June 30, 2023 - The CDC director gave a green light to two RSV vaccines for older people, from Pfizer and GSK —making them the first to become publicly available in the U.S.

September 25, 2024 - Information about RSV immunizations to help protect you from severe RSV illness.

Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are ...

September 19, 2024 - Information on vaccines to protect adults ages 60 and older against RSV.

An official website of the United States government · The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site